Taysha Gene Therapies' positive results from the REVEAL study showcase TSHA-102's promise in treating Rett Syndrome. Click ...

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...

LONDON, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has filed an amendment to the clinical protocol for its ongoing Phase ...

Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial. Clinical trial participation can help ...

The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...

For kidney transplant recipient Janet Handal, the recent push to phase out COVID-19 research could have a deadly outcome. In early 2021, Handal participated in a study that found almost half of ...

"Our partnership with Recursion underscores the transformative potential of real-world data in driving smarter clinical trials," said Andrew Kress, CEO of HealthVerity. "By providing seamless ...

Clinical trials allow doctors and researchers to evaluate the effectiveness and safety of various medical treatments. A person with a greater chance of developing a specific condition who meets ...

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched. BELLA, a phase 2 clinical trial evaluating the ...

Spokespeople for Eli Lilly, Bristol Myers Squibb, Sanofi and Roche’s Genentech confirmed in emails to Fierce Biotech that their work on advancing clinical trial diversity remains ongoing.

India's clinical trial share at 8%, compared to China's 29% as of 2022 Regulatory changes and tech investment needed for India Advertising trials could improve patient recruitment in India ...